Research & Development: Page 48
-
PharmaVoice Team/PharmaVoice
C-Suite: CROs
C-Suite: CROs By Taren Grom, Editor Contract Research Organizations We asked C-suite executives throughout the CRO arena to provide their insights on what the biggest opportunities and barriers for innovation are for improving the drug development process, as well as identify a recent innovation ...
By Taren Grom • March 27, 2014 -
PharmaVoice Team/PharmaVoice
PharmaTrax
Pharma Trax Sales, Marketing, and R&D Trends from Industry Analysts Featured Briefs: Diagnosis of Rare Diseases Remains Difficult Breakthrough Designation Has Potential to Shorten Development Time Cross-Functional Communication of Regulatory Strategy Boosts Impact Growth Expected in eClinical...
By Denise Myshko • March 27, 2014 -
Explore the Trendline➔
Stock via Getty Images
TrendlineOncology
As investments in cancer R&D stay high, waves of innovative new treatments are on the horizon.
By PharmaVoice staff -
PharmaVoice Team/PharmaVoice
Tools of the Trade
Tools of the Trade New Electronic and Web-based Applications, Sites, and Technologies Featured Briefs: PharmaKinnex Launches Physician Engagement Tool ZS Associates Releases Business Intelligence Tool Accelrys Launches Cloud for Discovery Partnerships TrialNetworks Launches Directory for Trial C...
By Denise Myshko • March 27, 2014 -
PharmaVoice Team/PharmaVoice
What's New
What’s New New Healthcare-related Products, Services, and Companies Featured Briefs: New Janssen Group To Target Unmet Global Health Needs Caplan Associates Launches Grad Advantage New Agency Network Deloitte Launches ConvergeHealth PDR Launches 4th Channel FDA and European Medicines Agency Stren...
By Ann Grey • March 27, 2014 -
PharmaVoice Team/PharmaVoice
Social Buzz
New Social Media News, Events, and Strategies Featured Briefs: Novo Nordisk Tackles Diabetes FDA Seeks Help with Digital Monitoring Android App Provides Power for Clinical Research Pfizer CEO Ian Read Featured on LinkedIn’s Influencer Page PROTECT Act Causing a Stir, But Doubtful to Pass Greater ...
By Taren Grom • March 27, 2014 -
PharmaVoice Team/PharmaVoice
Innovator's Corner
Innovator’s Corner DNA Analysis at the Site of Care Max Perelman, Co-founder of Biomeme, wants to turn your smartphone into a lab for quick DNA diagnostics and on-site disease tracking. We want to empower anyone to do the entire qPCR process from start to finish, and to do this we’ve dramaticall...
By Max Perelman • March 27, 2014 -
PharmaVoice Team/PharmaVoice
UpFront
UpFront AbbVie Announces Art Gallery On Chronic Inflammatory Disease AbbVie has launched Perspectives — Art, Inflammation and Me, an initiative designed to add a different dimension to the current understanding of immune-mediated inflammatory diseases and their impact on patients and society. Mo...
By Denise Myshko • March 27, 2014 -
PharmaVoice Team/PharmaVoice
Letter from the Editor
The Journey of an Entrepreneur: Risk and Reward Having embarked upon an entrepreneurial journey with my two business partners Lisa Banket and Marah Walsh 13 years ago, I was interested to read the stories of the entrepreneurs featured in this month’s cover story. Some are first timers, others are...
By Taren Grom • March 27, 2014 -
PharmaVoice Team/PharmaVoice
Insights Hidden in Data Represent Opportunities for Drug and Medical Device Developers
As speed and cost become increasingly important in health care, more and more decision making will be “shared," requiring increased data transparency, collection and analysis. Pharmaceutical and medical device innovators can now generate substantial value across the health care spectrum by levera...
By Doug Dockhorn • Feb. 26, 2014 -
PharmaVoice Team/PharmaVoice
mHealth Tools Can Streamline Clinical Trials
mHealth Tools Can Streamline Clinical Trials Studies show that mobile tools increase trial engagement while lowering costs. By Robin Robinson You may be holding the most important medical devices of the future in your hand: a smartphone and a mobile app. As the clinical trial space explores ways ...
By Robin Robinson • Feb. 25, 2014 -
PharmaVoice Team/PharmaVoice
Connected Health Tools Improve Patient Outcomes
connected Health Tools Improve Patient Outcomes The ability for real-time information exchange enables better relationships, monitoring, and behavior change. By Robin Robinson The Center for Connected Health has been studying the effects of connected health on patient behavior, engagement, and ou...
By Robin Robinson • Feb. 25, 2014 -
PharmaVoice Team/PharmaVoice
mHealth: Patient Adherence Tools Get Personal
mhealth Patient Adherence Tools Get Personal From blister packaging to text reminders, mHealth technology tools are helping drive patient adherence. Acharacteristically slow-moving pharma industry is being hit with technology that is changing at warp speed. How companies prepare for the coming ye...
By Robin Robinson • Feb. 25, 2014 -
PharmaVoice Team/PharmaVoice
Connected Health
Connected Health According to Accenture, the future of healthcare is an ecosystem that is based on connecting all parts of a healthcare delivery system, seamlessly, through interoperable health information processes and technologies so that critical health information is available when and where ...
By Taren Grom • Feb. 25, 2014 -
PharmaVoice Team/PharmaVoice
Talent Pool
Pharma Pool Albert BOURLA Susan SILBERMANN Pfizer Makes Executive Moves Pfizer has named Albert Bourla as group president of the vaccines, oncology, and consumer healthcare business. Mr. Bourla has 20 years of experience at Pfizer and has held senior global positions across a range of markets and...
By Ann Grey • Feb. 25, 2014 -
PharmaVoice Team/PharmaVoice
On the Calendar
On the Calendar The Calendar Industry Events and Conferences, including special discounts Coming Attractions In May 2014, the Healthcare Businesswomen’s Association is celebrating the 25th anniversary of its prestigious Woman of the Year (WOTY) award. The HBA is proud to announce that three vis...
By Heather Hummel • Feb. 25, 2014 -
PharmaVoice Team/PharmaVoice
Upping Their Game: CROs Must Develop A New Mindset to Partners with Sponsors
Contributed by: Mark Scullion, Senior VP, Strategic Resourcing, Inventiv Health Clinical As companies evaluate CRO partners, even for transactional work, they should be considering their potential fit for a more aligned relationship in the future. Forming an aligned partnership can lower costs, r...
By Mark Scullion • Jan. 28, 2014 -
PharmaVoice Team/PharmaVoice
Creating Sustainable Growth, Profitability, and Innovation
Balkrishan Kalra, Senior Vice President & Global Business Leader, Life Sciences, Genpact Can your business process operations support disruptive new strategies, and nontraditional business models? Today, the life sciences industry faces unprecedented challenges, uncertainty and risk that are ...
By Balkrishan Kalra • Jan. 28, 2014 -
PharmaVoice Team/PharmaVoice
SHOWCASE FEATURE: Outsourcing: Adding Value to the Model
SHOWCASE FEATURE: Outsourcing: Outsourcing: Adding Value to the Model By Tarem Grom, Editor Outsourcing has become a standard worldwide business practice and management imperative and stakeholders are looking for more than cost- savings. A relatively small number of BPO clients — 20% of those par...
By Taren Grom • Jan. 28, 2014 -
PharmaVoice Team/PharmaVoice
Singapore a Pharma Hub for Asia
Singapore a Pharma Hub for Asia By Kim Ribbink The pharma industry is increasingly drawn to Singapore, thanks to its commitment to research and innovation, good talent base, and trusted regulatory and IP environment. Singapore is fast becoming a leading regional and even global center for the lif...
By Kim Ribbink • Jan. 28, 2014 -
PharmaVoice Team/PharmaVoice
Rare Diseases: The Patient as Collaborator
In the rare disease market, working with patients and patient advocacy groups is critical for the success of new therapies. The voice of the patient is critical in healthcare. Nowhere is this more true than in the area of rare diseases. It’s critical to engage patients, industry experts say, to a...
By Denise Myshko • Jan. 28, 2014 -
PharmaVoice Team/PharmaVoice
Specialty Drugs: An Evolving Commercial Model
A changing marketplace creates new challenges and new business models for specialty medications. At the same time the industry is increasing its focus on developing specialty drugs — a projected 40% growth by 2014 and 67% by 2015, according to Express Scripts — the reimbursement, marketing, and s...
By Robin Robinson • Jan. 28, 2014 -
PharmaVoice Team/PharmaVoice
Last Word
Biopharmaceutical companies are becoming more fully engaged with patients as well as patient advocacy groups. Millennium’s head of patient advocacy, Tom Sellers, discusses the barriers and opportunities that early engagement entails. PV:What has precluded biopharmaceutical companies from early ...
By Tom Sellers • Jan. 28, 2014 -
PharmaVoice Team/PharmaVoice
Talent Pool
Pharma Pool Dr. Yong-Jun LIU Medimmune Names New Head of Research MedImmune, the global biologics research and development arm of AstraZeneca, has named Yong-Jun Liu, M.D., Ph.D., as the company’s new head of research. Most recently, Dr. Liu served as VP and chief scientific officer at the Baylo...
By Ann Grey • Jan. 28, 2014 -
PharmaVoice Team/PharmaVoice
PharmaTrax
Pipelines are Shifting to Biotech Drugs Trending Now: Large molecules currently represent a dominant share of sales. The pharmaceutical industry, especially big pharma, has dramatically shifted its R&D focus from its historical concentration on small molecule drugs to include a rapidly increa...
By Denise Myshko • Jan. 28, 2014 -
PharmaVoice Team/PharmaVoice
Tools of the Trade
GSW Launches Multi-Channel Detailing Platform Trending Now: eDetailing allows for increased flexibility and access to physicians in a changing salesforce landscape. GSW, an inVentiv Health company and healthcare communications agency, has released iQ.mercury 3, a significant advance in pharmaceut...
By Denise Myshko • Jan. 28, 2014
Previous
